Kidney-sparing immunotherapy for lynch syndrome-associated upper tract urothelial carcinoma following colon cancer: a case report
Haibiao Xie, Qifan Xie, Chunxiang Feng, Kun Wei, Fangqianyu Zhong, Jie Wen, Jiawei Gao, Xiaoyong Pu, Chujin Ye · 2026
Read Kidney-sparing immunotherapy for lynch syndrome-associated upper tract urothelial carcinoma following colon cancer: a case report by Haibiao Xie, Qifan Xie, Chunxiang Feng, Kun Wei, Fangqianyu Zhong, Jie Wen, Jiawei Gao, Xiaoyong Pu, Chujin Ye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13630660.txt.
Description
Haibiao Xie and co-authors report a kidney-sparing treatment for a woman with Lynch syndrome. Their twenty twenty-six case report follows her from colon cancer to a second cancer in the upper urinary tract. Lynch syndrome is an inherited trait that raises risk for many cancers.
Surgery first removed part of her colon, and tests showed a repair defect in the tumor. Ten months later a mass grew in her right kidney pelvis. A scope biopsy proved it was a new cancer, not spread from the colon. Immune therapy then treated the tract cancer while sparing the kidney, a path readers can weigh for like cases.
Catalog record
| CREATOR | Haibiao Xie, Qifan Xie, Chunxiang Feng, Kun Wei, Fangqianyu Zhong, Jie Wen, Jiawei Gao, Xiaoyong Pu, Chujin Ye |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |